Teitur Trophics
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $30M
Investors
- 5
About Teitur Trophics
Based in Aarhus, Denmark, and founded in 2020 by Simon Molgaard (CEO), Anders Dalby, Mathias Kaas Ollendorff, and Simon Glerup, Teitur Trophics operates as a biotechnology research company developing circular peptides for the treatment of neurodegenerative disorders, such as Huntington’s disease, Parkinson’s disease, and frontotemporal dementia. Teitur Trophics is an operator of a medical research company that is being studied on small peptides involved in neurodegenerative diseases such as Huntington's, Alzheimer's, and Parkinson's disease. Furthermore, the firm's research focuses on receptors that are central to neural function, and by understanding the biology of the receptor, healthcare experts can modulate key mechanisms in neural function, allowing them to develop treatments that can prevent disease development through daily injections.
Who invested in Teitur Trophics
5 investors across 1 round
See all investors in Teitur Trophics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 14, 2023
Amount
$30M
Investors
Questions about Teitur Trophics
Who invested in Teitur Trophics?
Teitur Trophics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Teitur Trophics raised?
Teitur Trophics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Teitur Trophics last raise money?
Teitur Trophics's most recent round on record is a Series A, in Mar 2023.
What does Teitur Trophics do?
Based in Aarhus, Denmark, and founded in 2020 by Simon Molgaard (CEO), Anders Dalby, Mathias Kaas Ollendorff, and Simon Glerup, Teitur Trophics operates as a biotechnology research company developing circular peptides for the treatment of neurodegenerative disorders, such as Huntington’s disease, Parkinson’s disease, and frontotemporal dementia.
Where is Teitur Trophics headquartered?
Teitur Trophics is headquartered in Denmark.
Which VCs invest in companies like Teitur Trophics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Teitur Trophics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Teitur Trophics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.